Dr. Emmanuel Musa is a medical doctor, clinical scientist, epidemiologist, and public health expert. He served as team lead for High Impact Epidemics for the World Health Organization's Health Emergency Programme in Geneva, Switzerland, and as senior medical officer for Emergency Risk Management, responsible for technical support to 47 countries under the Africa Regional Office of WHO in Brazzaville, Congo. The Health Emergencies Programme of the WHO is responsible for delivering global assistance to countries to help them prepare for and respond effectively to health emergencies such as disease outbreaks, pandemics, and disasters.
Dr. Musa began working with the WHO in Nigeria in April 2001 and spent the next two decades in various operational and leadership roles in disease outbreaks, emergencies, humanitarian aid, polio eradication initiative, primary healthcare, and building resilient health systems in several countries. His contributions significantly strengthened health systems and enhanced emergency preparedness, response capacities, and disease prevention and control initiatives. Before joining WHO, he served in teaching, research, oversight, and leadership roles in clinical, community health, primary healthcare system management, and undergraduate and postgraduate medical education in Africa.
Dr. Musa holds an MD, MPH, and a Master of Science in Health Systems Management (Liverpool, United Kingdom). He is a PhD candidate in health research at the University of Bath in the United Kingdom. He also holds a Global Health Diplomacy Certificate from The State University of New York, Albany, and a fellow by distinction of the Faculty of Public Health Medicine, Royal College of Physicians of the United Kingdom. Dr. Musa's current areas of interest include global health research, infectious disease epidemiology, clinical public health, humanitarian aid, climate change and impact on health, developing health system resilience, digital public health intelligence/surveillance systems, and global health security. With a relentless determination to positively impact global health, Dr. Musa continues to apply innovative approaches and an unwavering commitment to improving the well-being of individuals and communities throughout the world.
Research keywords:
Early Warning Systems; Public Health Intelligence; Disease Surveillance; Innovative digital solutions; artificial intelligence; Optimizing vaccine delivery; Immunization strategies; low-resource settings; hard-to-reach populations; effective health services; efficient health services; Primary Health Care; Universal Health Coverage; health system resilience; post-conflict settings; post-disaster settings; humanitarian aid; humanitarian settings; infectious disease epidemiology; clinical public health; climate change; health impact; digital health technologies; public health systems; global health security.
Themes | Global Health & Humanitarianism |
Status | Active |
Events |
Addressing Inequities in Access to Medical Countermeasures During Health and Humanitarian Emergencies: My Lived Experience, with Emmanuel Musa | September 11, 2023 |
Related Work |
N/A
|
Updates |
Opportunity - Experiential Learning in Global Health WI25 | November 18, 2024
Recap – Promoting Global Health Equity Through Improved Access to Medical Countermeasures | October 19, 2023 |
You may also be interested in...
Dahdaleh Faculty Fellows Receive Lassonde Research and Impact Awards
Three outstanding Dahdaleh faculty fellows received Lassonde Research Awards Celebration recognizing their exemplary achievements. Professor Stephanie Gora received Lassonde Innovation Fund in Category C: Research Projects Working Directly on or Towards one of the UN ...Read more about this Post
Dahdaleh Institute Researchers Awarded Over $1.4M from New Frontiers in Research Fund
Originally published by Yfile (4 May 2023). Written by Corey Allen, senior manager, research communications Seven projects led by York University researchers were awarded a combined $2.4 million from the New Frontiers in Research Fund (NFRF) in ...Read more about this Post
Global Strategy Lab awarded $8.7M to create AMR Policy Accelerator
Antimicrobial resistance (AMR) is one of the greatest threats humanity faces today. Decades of use, overuse and misuse of antimicrobials in animals and humans has led to the development of bacteria, viruses, fungi and parasites ...Read more about this Post